User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium.

  1. Malfertheiner P., Megraud F., O'Morain C., Hungin A. P. S., Jones R., Axon A., Graham D. Y., Tytgat G., , Current concepts in the management of Helicobacter pylori infection-The Maastricht 2-2000 Consensus Report, 10.1046/j.1365-2036.2002.01169.x
  2. Megraud F, H pylori antibiotic resistance: prevalence, importance, and advances in testing, 10.1136/gut.2003.022111
  3. Fischbach Lori A, Goodman Karen J, Feldman Mark, Aragaki Corinne, Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis, 10.1093/ije/31.1.128
  4. Fischbach L. A., Zanten S. V., Dickason J., Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies, 10.1111/j.1365-2036.2004.02248.x
  5. Lee J. H., Shin J.-H., Roe I. H., Sohn S. G., Lee J. H., Kang G. H., Lee H.-K., Jeong B. C., Lee S. H., Impact of Clarithromycin Resistance on Eradication of Helicobacter pylori in Infected Adults, 10.1128/aac.49.4.1600-1603.2005
  6. Antos David, Schneider-Brachert Wulf, Bastlein Elke, Hanel Christine, Haferland Christian, Buchner Michael, Meier Eberhard, Trump Friedrich, Stolte Manfred, Lehn Norbert, Bayerdorffer Ekkehard, 7-Day Triple Therapy of Helicobacter pylori Infection with Levofloxacin, Amoxicillin, and High-Dose Esomeprazole in Patients with Known Antimicrobial Sensitivity, 10.1111/j.0083-8703.2006.00375.x
  7. Gisbert Javier P., Castro-Fernandez Manuel, Bermejo Fernando, Perez-Aisa Angeles, Ducons Julio, Fernandez-Bermejo Miguel, Bory Felipe, Cosme Angel, Benito Luis-Miguel, Lopez-Rivas Laureano, Lamas Eloisa, Pabon Manuel, Olivares David, , Third-Line Rescue Therapy with Levofloxacin After Two H. pylori Treatment Failures, 10.1111/j.1572-0241.2006.00457.x
  8. GISBERT J. P., MORENA F., Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure, 10.1111/j.1365-2036.2006.02737.x
  9. WONG W. M., GU Q., CHU K.-M., YEE Y. K., FUNG F. M. Y., TONG T. S. M., CHAN A. O. O., LAI K. C., CHAN C. K., WONG B. C. Y., Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection, 10.1111/j.1365-2036.2006.02764.x
  10. Debets-Ossenkopp Y. J., Herscheid A. J., Pot R. G. J., Kuipers E. J., Kusters J. G., Vandenbroucke-Grauls C. M. J. E., Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands, 10.1093/jac/43.4.511
  11. Cabrita J., Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999), 10.1093/jac/46.6.1029
  12. Boyanova L., Mentis A., Gubina M., Rozynek E., Gosciniak G., Kalenic S., Göral V., Kupcinskas L., Kantarçeken B., Aydin A., Archimandritis A., Dzierżanowska D., Vcev A., Ivanova K., Marina M., Mitov I., Petrov P., Özden A., Popova M., The status of antimicrobial resistance of Helicobacter pylori in eastern Europe, 10.1046/j.1469-0691.2002.00435.x
  13. Tankovic J., Lascols C., Sculo Q., Petit J.-C., Soussy C.-J., Single and Double Mutations in gyrA but Not in gyrB Are Associated with Low- and High-Level Fluoroquinolone Resistance in Helicobacter pylori, 10.1128/aac.47.12.3942-3944.2003
  14. Fujimura S., In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children, 10.1099/jmm.0.45642-0
  15. Cattoir V, Helicobacter, 10, 542 (2005)
  16. Kim Jung Mogg, Kim Joo Sung, Kim Nayoung, Jung Hyun Chae, Song In Sung, Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients, 10.1093/jac/dki334
  17. Perez Aldana L., Kato M., Nakagawa S., Kawarasaki M., Nagasako T., Mizushima T., Oda H., Kodaira J., Shimizu Y., Komatsu Y., Zheng R., Takeda H., Sugiyama T., Asaka M., The Relationship Between Consumption of Antimicrobial Agents and the Prevalence of Primary Helicobacter pylori Resistance, 10.1046/j.1523-5378.2002.00096.x
  18. 18 H Goossens, M Ferech, R Vander Stichele, M. Elseviers, and ESAC Project Group. and Outpatient antibiotic use in Europe and association with resistance: a cross-national database study . Lancet, 2005 : 365 (9459, 579-87.
  19. Moore R. A., Beckthold B., Wong S., Kureishi A., Bryan L. E., Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori, 10.1128/aac.39.1.107
  20. Glocker E., Kist M., Rapid Detection of Point Mutations in the gyrA Gene of Helicobacter pylori Conferring Resistance to Ciprofloxacin by a Fluorescence Resonance Energy Transfer-Based Real-Time PCR Approach, 10.1128/jcm.42.5.2241-2246.2004
  21. Haas C E, Nix D E, Schentag J J, In vitro selection of resistant Helicobacter pylori., 10.1128/aac.34.9.1637
  22. Wang G., Wilson T. J. M., Jiang Q., Taylor D. E., Spontaneous Mutations That Confer Antibiotic Resistance in Helicobacter pylori, 10.1128/aac.45.3.727-733.2001
  23. Y. Glupczynski, N. Broutet, A. Cantagrel, L. Andersen, T. Alarcon, M. López-Brea, F. Mégraud, Comparison of the E Test and Agar Dilution Method for Antimicrobial Suceptibility Testing of Helicobacter pylori, 10.1007/s10096-002-0757-6
Bibliographic reference Bogaerts, Pierre ; Berhin, Catherine ; Nizet, Henri ; Glupczynski, Gerald. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium.. In: Helicobacter, Vol. 11, no. 5, p. 441-5 (2006)
Permanent URL